Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-22-058095

Chief Development Officer sold 3,289 shares at an average $15.85 ($52,128)

  • Chief Development Officer acquired 3,289 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Curley Joanne Chief Development Officer 2022-11-17 Option exercise +1,078 $6.37 $6,870 28,393 D
Curley Joanne Chief Development Officer 2022-11-17 Sale −1,078 $15.86 $17,098 27,315 D
Curley Joanne Chief Development Officer 2022-11-17 Option exercise +2,211 $2.90 $6,405 29,526 D
Curley Joanne Chief Development Officer 2022-11-17 Sale −2,211 $15.84 $35,030 27,315 D
Derivatives
Curley Joanne Chief Development Officer 2022-11-17 Option exercise · Stock Option (right to buy) −1,078 9,717 D
Curley Joanne Chief Development Officer 2022-11-17 Option exercise · Stock Option (right to buy) −2,211 38,013 D
Open-market sales · 3,289 sh · avg $15.85 · $52,128
Loading xslF345X03/doc4.xml…